Author:
Rumsby M,Schmitt J,Sharrard M,Rodrigues G,Stower M,Maitland N
Publisher
Springer Science and Business Media LLC
Reference96 articles.
1. Ackerstaff E, Pflug BR, Nelson JB, Bhujwalla ZM (2001) Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res 61: 3599–3603
2. Alessi D (1997) The protein kinase C inhibitors Ro318220 and GF 109203X are equally potent inhibitors of MAPKAP kinase-1β (Rsk-2) and p70S6 kinase. FEBS Lett 402: 121–123
3. Ali AS, Ali S, El-Rayes BF, Philip PA, Sarkar FH (2009) Exploitation of protein kinase C: useful target for cancer therapy. Cancer Treat Rev 35: 1–8
4. Baba S, Engles J, Wahl R (2007) Choline uptake and RNA expression profile in cancerous and normal prostate cell lines: No significant role of choline transporter in PET tracer uptake. J Nucl Med 48 (Supp 2): 335P
5. Beloueche-Babari M, Peak JC, Jackson LE, Tiet M-Y, Leach MO, Eccles SA (2009) Changes in choline metabolism as potential biomarkers of phospholipase Cγ1 inhibition in human prostate cancer cells. Mol Cancer Ther 8: 1305–1311
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献